Frequency of high-risk patients not receiving high-potency statin (from a Large Managed Care Database)

American Journal of Cardiology

Volumn 115, Issue 2, 2015, Pages 190-195

  Rodriguez, Fatima ^a   Olufade, Temitope ^b   Heithoff, Kim ^b   Friedman, Howard S ^c   Navaratnam, Prakash ^c   Foody, Joanne M ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Data Solutions LLC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BILE ACID SEQUESTRANT; EZETIMIBE; FIBRIC ACID DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 FATTY ACID; ROSUVASTATIN; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DRUG USE; FEMALE; GOAL ATTAINMENT; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PRACTICE GUIDELINE; PRESCRIPTION; REFERENCE DATABASE; RETROSPECTIVE STUDY; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; FACTUAL DATABASE; FOLLOW UP; HEALTH INSURANCE; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; RISK FACTOR; UNITED STATES;

CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84919665684     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.10.021     Document Type: Article

References (19)

1. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, R. Simes Cholesterol Treatment Trialists Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
2. C.P. Cannon, B.A. Steinberg, S.A. Murphy, J.L. Mega, and E. Braunwald Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol 48 2006 438 445
3. M.J. Koren, and D.B. Hunninghake Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study J Am Coll Cardiol 44 2004 1772 1779
4. M.D. Carroll, B.K. Kit, D.A. Lacher, S.T. Shero, and M.E. Mussolino Trends in lipids and lipoproteins in US adults, 1988-2010 JAMA 308 2012 1545 1554
5. E.V. Kuklina, P.W. Yoon, and N.L. Keenan Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006 JAMA 302 2009 2104 2110
6. J.M. Foody, S.G. Sajjan, X.H. Hu, D.R. Ramey, D.R. Neff, A.M. Tershakovec, J.E. Tomassini, C. Wentworth, and K. Tunceli Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients J Clin Lipidol 4 2010 126 132
7. T.A. Pearson, I. Laurora, H. Chu, and S. Kafonek The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459 467
8. H.W. Kaufman, A.J. Blatt, X. Huang, M.A. Odeh, and H.R. Superko Blood cholesterol trends 2001-2011 in the United States: analysis of 105 million patient records PLoS One 8 2013 e63416
9. M.C. Tattersall, R.E. Gangnon, K.N. Karmali, M.W. Cullen, J.H. Stein, and J.G. Keevil Trends in low-density lipoprotein cholesterol goal achievement in high risk United States adults: longitudinal findings from the 1999-2008 National Health and Nutrition Examination Surveys PLoS One 8 2013 e59309
10. T.A. Stacy, and A. Egger Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs J Manag Care Pharm 12 2006 745 751
11. J.F. Keaney Jr., G.D. Curfman, and J.A. Jarcho A pragmatic view of the new cholesterol treatment guidelines N Engl J Med 370 2014 275 278
12. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, D.M. Lloyd-Jones, C.B. Blum, P. McBride, R.H. Eckel, J.S. Schwartz, A.C. Goldberg, S.T. Shero, D. Gordon, S.C. Smith Jr., D. Levy, K. Watson, and P.W. Wilson 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 64 2014 2935 2959
13. D. Giugliano, and K. Esposito Clinical inertia as a clinical safeguard JAMA 305 2011 1591 1592
14. K.C. Goldberg, S.D. Melnyk, and D.L. Simel Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol Am J Manag Care 13 2007 530 534
15. S.S. Virani, L.D. Woodard, D. Wang, S.S. Chitwood, C.R. Landrum, T.H. Urech, K. Pietz, G.J. Chen, B. Hertz, J. Murawsky, C.M. Ballantyne, and L.A. Petersen Correlates of repeat lipid testing in patients with coronary heart disease JAMA Intern Med 173 2013 1439 1444
16. M.D. Cabana, C.S. Rand, N.R. Powe, A.W. Wu, M.H. Wilson, P.A. Abboud, and H.R. Rubin Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
17. P.P. Toth, C.M. Ballantyne, M.H. Davidson, J.E. Tomassini, D.R. Ramey, D. Neff, A.M. Tershakovec, X.H. Hu, and K. Tunceli Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction J Clin Lipidol 6 2012 180 191
18. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment Eur Heart J 34 2013 1279 1291
19. W.E. Boden, J.L. Probstfield, T. Anderson, B.R. Chaitman, P. Desvignes-Nickens, K. Koprowicz, R. McBride, K. Teo, and W. Weintraub Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267